2010-08-23
Torbjörn Bjerke has been appointed as new CEO for Karolinska Development. He is currently CEO for Orexo, a position he has held since 2007. Torbjörn Bjerke succeeds Conny Bogentoft who will assume the position as Chief Scientific Officer for Karolinska Development.Starting its operation in 2003, ... |
2010-08-03
A new vaccine, which knocks out the blood supply to tumors, has proved very effective in mice. Tumor growth is reduced by as much as 70 percent. Behind the study, which was recently published in the FASEB Journal, is a research group from Uppsala University. The next step is to test the vaccine in ... |
2010-08-30
Meda has signed an agreement to acquire the US specialty pharmaceutical company Alaven. The acquisition will significantly enhance Meda's marketing capabilities in the US and expand the therapeutic focus to include both gastroenterology and women's health; areas that Meda already operates in ... |
|
2010-08-19
It shows in this year's edition of the prestigious Shanghai rank. Three Swedish universities are among the 80 best and all from the Stockholm-Uppsala region.Every year, the Shanghai Jiao Tong University publishes a ranking of the world's best universities – the so-called Shanghai ranking. It is one ... |
2010-07-23
Meda has reached an agreement with the Spanish pharma company Almirall about a respiratory combination project in the Novolizer device that Meda had certain rights to. The project is in research phase, and Almirall has purchased Meda’s rights for 45 million EUR. If questions, please contact: Anders ... |
2010-07-20
Multiple myeloma is one of the most common blood cancers, and at present considered to be incurable. In a new study from Uppsala University, researchers now present a conceptually new model for the development and progression of multiple myeloma.The study was done in collaboration with Vrije ... |
|